ValuEngine cut shares of CR AGRICOLE S A/ADR (OTCMKTS:CRARY) from a sell rating to a strong sell rating in a report released on Wednesday, ValuEngine reports.

Separately, Zacks Investment Research lowered CR AGRICOLE S A/ADR from a hold rating to a sell rating in a research note on Thursday, November 7th.

OTCMKTS:CRARY traded up $0.04 during trading hours on Wednesday, hitting $6.86. 79,600 shares of the stock were exchanged, compared to its average volume of 136,309. CR AGRICOLE S A/ADR has a 52-week low of $5.11 and a 52-week high of $7.02. The firm’s fifty day moving average price is $6.30 and its 200 day moving average price is $6.05. The company has a market cap of $38.73 billion, a P/E ratio of 8.37 and a beta of 1.47.

CR AGRICOLE S A/ADR (OTCMKTS:CRARY) last posted its quarterly earnings data on Friday, November 8th. The company reported $0.19 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.20 by ($0.01). The business had revenue of $5.59 billion during the quarter. As a group, sell-side analysts expect that CR AGRICOLE S A/ADR will post 0.68 earnings per share for the current fiscal year.

CR AGRICOLE S A/ADR Company Profile

Cr̩dit Agricole SA provides retail, corporate, insurance, and investment banking products and services worldwide. It operates through five segments: Asset Gathering; French Retail Banking РLCL; International Retail Banking; Specialised Financial Services; and Large Customers. The company offers payment instruments, loans, and saving products; savings/retirement, death and disability/creditor/group, and property and casualty insurance products; and expertise and investment solutions for active, passive, real estate, and alternative asset management.

Further Reading: Short Selling Stocks and Day Traders

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for CR AGRICOLE S A/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CR AGRICOLE S A/ADR and related companies with MarketBeat.com's FREE daily email newsletter.